ARVINAS INC
ARVNNASDAQ🏆 #2997 by market capEarnings Nov 3US Equity
$7.50▼ $0.01 (−0.13%)
🌙 After hours$7.50▲ 0.00%Regular close · extended-hours price shownTrack ARVN
Get earnings, price moves & breaking news on Telegram
24h▼ 0.1%
7d▼ 4.1%
14d▼ 8.1%
30d▼ 18.5%
ytd▼ 36.8%
1y▼ 12.0%
🏦Market Cap
$484M
Small Cap
📈Revenue Growth (YoY)
-0.3%
Declining
📊Gross Margin
96.4%
High
💵FCF Margin
-65.9%
Thin
⚖️P/S Ratio
1.5x
Cheap
Otter Score
88
Very Good
ARVINAS INC
ARVNAnalyst Ratings
Price
$7.50
Total
26
Raised
0
Lowered
5
Avg PT
$14.17
H / L
$20 / $10
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Evercore ISI Group | Reiterated | Outperform | 2026-08-10 | — | — |
Citigroup | Reiterated | Buy | 2026-08-10 | $72.00 | +860.00% |
Wedbush | Reiterated | Neutral | 2026-08-05 | $12.00 | +60.00% |
Wells Fargo | Downgraded | Overweight → Equal Weight | 2026-08-05 | $11.00 | +46.70% |
BTIG | Reiterated | Buy | 2026-08-04 | $18.00 | +140.00% |
Stephens & Co. | Reiterated | Overweight | 2026-06-03 | — | — |
Barclays | Reiterated | Overweight | 2026-05-13 | $20.00 | +166.70% |
Piper Sandler | Reiterated | Overweight | 2026-02-25 | $16.00 | +113.30% |
Goldman Sachs | Downgraded | Neutral → Sell | 2025-10-15 | $6.00 | −20.00% |
HC Wainwright & Co. | Reiterated | Buy | 2025-08-07 | — | — |
Guggenheim | Reiterated | Buy | 2025-08-07 | — | — |
Leerink Partners | Downgraded | Outperform → Market Perform | 2025-06-02 | $62.00 | +726.70% |
UBS | Reiterated | Buy | 2025-05-15 | $123.00 | +1540.00% |
Morgan Stanley | Reiterated | Equal Weight | 2025-05-09 | $10.00 | +33.30% |
Truist Securities | Downgraded | Buy → Hold | 2025-05-05 | — | — |
BMO Capital | Reiterated | Outperform | 2025-05-05 | $20.00 | +166.70% |
Jefferies | Downgraded | Buy → Hold | 2025-05-02 | — | — |
B of A Securities | Reiterated | Buy | 2025-03-12 | — | — |
Oppenheimer | Reiterated | Outperform | 2025-02-12 | $40.00 | +433.30% |
Stifel | Reiterated | Buy | 2025-02-12 | — | — |
Cantor Fitzgerald | Reiterated | Overweight | 2025-02-07 | — | — |
Credit Suisse | Reiterated | Outperform | 2023-02-24 | — | — |
SVB Leerink | Reiterated | Outperform | 2022-11-23 | — | — |
Roth Capital | Reiterated | Buy | 2021-08-09 | — | — |
PiperJaffray | Reiterated | Overweight | 2020-01-06 | — | — |
Piper Jaffray | Reiterated | Overweight | 2019-11-13 | — | — |
Institution
Evercore ISI Group
Reiterated · Outperform · 2026-08-10
—
—
Citigroup
Reiterated · Buy · 2026-08-10
$72.00
+860.00%
Wedbush
Reiterated · Neutral · 2026-08-05
$12.00
+60.00%
Wells Fargo
Downgraded · Overweight → Equal Weight · 2026-08-05
$11.00
+46.70%
BTIG
Reiterated · Buy · 2026-08-04
$18.00
+140.00%
Stephens & Co.
Reiterated · Overweight · 2026-06-03
—
—
Barclays
Reiterated · Overweight · 2026-05-13
$20.00
+166.70%
Piper Sandler
Reiterated · Overweight · 2026-02-25
$16.00
+113.30%
Goldman Sachs
Downgraded · Neutral → Sell · 2025-10-15
$6.00
−20.00%
HC Wainwright & Co.
Reiterated · Buy · 2025-08-07
—
—
Guggenheim
Reiterated · Buy · 2025-08-07
—
—
Leerink Partners
Downgraded · Outperform → Market Perform · 2025-06-02
$62.00
+726.70%
UBS
Reiterated · Buy · 2025-05-15
$123.00
+1540.00%
Morgan Stanley
Reiterated · Equal Weight · 2025-05-09
$10.00
+33.30%
Truist Securities
Downgraded · Buy → Hold · 2025-05-05
—
—
BMO Capital
Reiterated · Outperform · 2025-05-05
$20.00
+166.70%
Jefferies
Downgraded · Buy → Hold · 2025-05-02
—
—
B of A Securities
Reiterated · Buy · 2025-03-12
—
—
Oppenheimer
Reiterated · Outperform · 2025-02-12
$40.00
+433.30%
Stifel
Reiterated · Buy · 2025-02-12
—
—
Cantor Fitzgerald
Reiterated · Overweight · 2025-02-07
—
—
Credit Suisse
Reiterated · Outperform · 2023-02-24
—
—
SVB Leerink
Reiterated · Outperform · 2022-11-23
—
—
Roth Capital
Reiterated · Buy · 2021-08-09
—
—
PiperJaffray
Reiterated · Overweight · 2020-01-06
—
—
Piper Jaffray
Reiterated · Overweight · 2019-11-13
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space